BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2335944)

  • 1. [Effect of Bonnecor on clinical manifestations, bioelectric cardiac activity and cardiac hemodynamics in patients with acute myocardial infarction and chronic ischemic heart disease].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Klin Med (Mosk); 1990 Feb; 68(2):44-6. PubMed ID: 2335944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical study of bonnecor in the treatment of heart rhythm disorders in patients with ischemic heart disease].
    Gorshkov VA; Solodukhina IS; Kesarev GV; Kurakina TI; Solov'eva FV
    Sov Med; 1991; (7):45-7. PubMed ID: 1948344
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of bonnecor in ischemic heart disease].
    Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
    Sov Med; 1990; (6):72-4. PubMed ID: 2396129
    [No Abstract]   [Full Text] [Related]  

  • 5. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of arrhythmias in chronic ischemic heart disease.
    Furukawa T; Myerburg RJ
    Cardiovasc Clin; 1992; 22(1):19-43. PubMed ID: 1728426
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
    Chichkanov GG; Tolmacheva EA; Lyskovtsev VV; Grigor'eva EK; Matsievskiĭ DD
    Farmakol Toksikol; 1990; 53(3):38-40. PubMed ID: 2387378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifibrillatory and anti-arrhythmic action of 3-carbethoxyamino-5-dimethylamino-acetyl iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on models of myocardial ischemia].
    Kaverina NV; Lyskovzev VV; Grigoreva JK; Senova ZP; Sulakvelidze MT; Grizenko AN
    Pharmazie; 1985 Dec; 40(12):845-7. PubMed ID: 3841599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of anti-arrhythmia therapy with bonnecor in middle-aged and elderly patients].
    Zaslavskaia RM; Mirskiĭ BA; Diagilev II
    Klin Med (Mosk); 1996; 74(2):30-2. PubMed ID: 8772098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
    Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of rhythm and conduction disorders in coronary atherosclerosis].
    Shopova VN
    Vrach Delo; 1972 Oct; 10():8-11. PubMed ID: 4658423
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute ischemic heart disease alters ventricular fibrillation waveform characteristics in out-of hospital cardiac arrest.
    Olasveengen TM; Eftestøl T; Gundersen K; Wik L; Sunde K
    Resuscitation; 2009 Apr; 80(4):412-7. PubMed ID: 19217199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
    De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
    Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of cardiac rhythm and conduction in acute myocardial infarct during the first 3 days and the effectiveness of their treatment].
    Kochlamazashvili AI
    Ter Arkh; 1975; 47(7):44-51. PubMed ID: 1224349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estimation of the P wave and PQ interval dispersion in patients after the myocardial infarction].
    Jołda-Mydłowska B; Kobusiak-Prokopowicz M; Negrusz-Kawecka M
    Pol Merkur Lekarski; 2005 Dec; 19(114):783-7. PubMed ID: 16521423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias associated with myocardial ischaemia and infarction.
    Botting JH; Curtis MJ; Walker MJ
    Mol Aspects Med; 1985; 8(4):307-422. PubMed ID: 3916014
    [No Abstract]   [Full Text] [Related]  

  • 19. Conduction abnormalities in the presence of acute myocardial infarction.
    Snipes JJ; Neal RW
    J Okla State Med Assoc; 1971 Apr; 64(4):141-7. PubMed ID: 5572849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of calcium antagonists].
    Klaus W
    Fortschr Med; 1984 Jul; 102(27-28):728-31. PubMed ID: 6479816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.